Clinical trial
Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
NCT00150202 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00150202 |
|---|---|
| Title | Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) |
| Official title | Clinical Study Of EYE001 In Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | pegaptanib sodium |
| Enrollment | 90 |
| Start date | Jul 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | May 7, 2007 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: